Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care
Open Access
- 28 April 2021
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2020.00110
Abstract
The novel coronavirus-related coronavirus disease 2019 (COVID-19) pandemic has been relentless in disrupting and overwhelming healthcare the world over. Clinical outcomes of COVID-19 in patients with chronic comorbidities, especially in those with metabolic syndrome, are well documented. Chronic liver disease and cirrhosis patients are a special sub-group, among whom the management of COVID-19 is challenging. Understanding the pathophysiology of COVID-19 in patients with cirrhosis and portal hypertension improves our identification of at-risk patients for disease progression that will further help compartmentalize generalized and specialized treatment options in this special patient group. In this exhaustive review, we critically review the impact of COVID-19 on the liver and in chronic liver disease and cirrhosis patients. We further discuss common features associated with the pathophysiology of COVID-19 and cirrhosis, based on the renin-angiotensin system and deliberate current literature on guidelines for the treatment of COVID-19 and extrapolate the same to the cirrhosis population to provide a concise and stepwise, evidence-based management for cirrhosis patients with severe and critical COVID-19. There are no specific management guidelines for cirrhosis patients with COVID-19 and current recommendations for treatment are as per guidelines for general population. Nevertheless, specific issues like avoiding corticosteroids in decompensated patients with variceal bleeding, suspected sepsis, high grade hepatic encephalopathy and acute kidney injury, use of early mechanical ventilation strategies in those with severe ascites and hepatopulmonary syndrome, avoidance of remdesivir in advanced liver disease, and application of liver-specific severity scores for prognostication and identification of futility need to be highlighted.Keywords
This publication has 97 references indexed in Scilit:
- Antibiotic prophylaxis in cirrhosis: Good and badJournal of Hepatology, 2016
- Glucocorticoids and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology, 2015
- The Effects of Intravenous Vitamin C on Point-of-Care Glucose MonitoringJournal of Burn Care & Research, 2015
- Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directionsJournal of Hepatology, 2014
- Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosisWorld Journal of Gastroenterology, 2014
- Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantationLiver Transplantation, 2011
- Extracorporeal membrane oxygenation as a bridge to liver transplantation for acute respiratory distress syndrome-induced life-threatening hypoxaemia aggravated by hepatopulmonary syndromeCritical Care, 2011
- Physiopathology of splanchnic vasodilation in portal hypertensionWorld Journal of Hepatology, 2010
- Liver disease and the renin–angiotensin system: Recent discoveries and clinical implicationsJournal of Gastroenterology and Hepatology, 2008
- Cardiopulmonary dysfunction in cirrhosisJournal of Gastroenterology and Hepatology, 1999